Brazil Minerals Receives Written Contract for Sale of Sand from Duas Barras Mine

Brazil Minerals, Inc., a U.S. company with revenues from sales of both polished and rough diamonds as well as gold, announced today that it had received a written contract for sale of sand from its Duas Barras mine in Brazil. Sand is a byproduct of the processing for diamonds and gold.

The sand is sought after by the construction industry for cement preparation and other uses as cities near the mine are growing.

BMIX sees this initial sales contract as an indication of the potential to capitalize on a scarce resource that it has in abundance. BMIX has recently tested its unprocessed sand, in natura, at the SGS-Geosol analytical laboratory. The results demonstrated silica levels of 97%, indicating high quality and meeting criteria for use in a wide range of applications.

BMIX is now studying volumetric analysis of the total amount of sand it has. The Company believes that the contract received and announced today would cover only a very small fraction of the amount of sand currently available. Furthermore, sand gets replenished as the diamond and gold recovery plant operates and produces it as a byproduct.

Marc Fogassa, CEO and Chairman of BMIX, commented, "Our goal is to increase cash flows to fund operations. Sand has virtually no additional cost to us. It provides revenue diversification from diamonds and gold and predictability as it is sitting in piles or in bays and ready for transport. We are excited about exploring the potential of this mineral to add value to us."

Source: http://www.brazil-minerals.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.